SAN
DIEGO, April 11, 2024 /PRNewswire/ -- Heron
Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology
company, today announced that it will host an Investor Day
on Wednesday, May 15, 2024 in New York City, beginning at
9:30 am ET. The event will include
presentations from members of the Company's leadership team
highlighting the renewed focus across the Acute Care and Oncology
franchises and panel discussions featuring patient and physician
experience with Heron's commercial products. The presentations will
also include updates on several ongoing initiatives in the Acute
Care franchise to expand reach and adoption.
The event will include a live webcast which will be archived and
available for replay after the event. Please visit the "Investors"
section of the Company website at Investor Resources - Heron
Therapeutics (herontx.com) to register for the webcast and for
additional information on the event.
About Heron Therapeutics, Inc.
Heron Therapeutics, Inc. is a commercial-stage
biotechnology company focused on improving the lives of patients by
developing and commercializing therapeutic innovations that improve
medical care. Our advanced science, patented technologies, and
innovative approach to drug discovery and development have allowed
us to create and commercialize a portfolio of products that aim to
advance the standard-of-care for acute care and oncology patients.
For more information, visit www.herontx.com.
Forward-looking Statements
This news release contains "forward-looking statements" as
defined by the Private Securities Litigation Reform Act of 1995.
Heron cautions readers that forward-looking statements are based on
management's expectations and assumptions as of the date of this
news release and are subject to certain risks and uncertainties
that could cause actual results to differ materially. These risks
and uncertainties include, but are not limited to, risks and
uncertainties identified in the company's filings with
the Securities and Exchange Commission. Forward-looking
statements reflect our analysis only on their stated date, and
Heron takes no obligation to update or revise these statements
except as may be required by law.
Investor Relations and Media Contact:
Ira Duarte
Executive Vice President, Chief Financial Officer
Heron Therapeutics, Inc.
iduarte@herontx.com
858-251-4400
View original content to download
multimedia:https://www.prnewswire.com/news-releases/heron-therapeutics-to-host-investor-day-on-may-15-2024-in-new-york-city-302114792.html
SOURCE Heron Therapeutics, Inc.